The no-reflow phenomenon is a common complication during primary percutaneous coronary intervention. It may be encountered in up to 50% of primary percutaneous coronary intervention cases. No-reflow results in higher morbidity and mortality due to impaired myocardial perfusion.
(2025). Efficacy of Intracoronary Epinephrine in STEMI Patients with Refractory Coronary No Reflow During Percutaneous Coronary Intervention. Cardiovascular Research Prove Journal, 9(1), -. doi: 10.21608/cvrepj.2025.438160
MLA
. "Efficacy of Intracoronary Epinephrine in STEMI Patients with Refractory Coronary No Reflow During Percutaneous Coronary Intervention", Cardiovascular Research Prove Journal, 9, 1, 2025, -. doi: 10.21608/cvrepj.2025.438160
HARVARD
(2025). 'Efficacy of Intracoronary Epinephrine in STEMI Patients with Refractory Coronary No Reflow During Percutaneous Coronary Intervention', Cardiovascular Research Prove Journal, 9(1), pp. -. doi: 10.21608/cvrepj.2025.438160
VANCOUVER
Efficacy of Intracoronary Epinephrine in STEMI Patients with Refractory Coronary No Reflow During Percutaneous Coronary Intervention. Cardiovascular Research Prove Journal, 2025; 9(1): -. doi: 10.21608/cvrepj.2025.438160
)
View on SCiNiTO